bioLIVE is a new focused event with an exhibition and a live content stage, focusing on large molecule Biopharma and more specifically on manufacturing and processing. A unique platform connecting biotechs, big pharma and service providers across the whole value chain in large molecules.
bioLIVE runs adjacent to CPhI Worldwide, bringing small and large molecule worlds together, creating a unique platform where both industries can learn from each other.
The unique synergies and the exceptional audience of CPhI Worldwide, with 45,000 visitors over 3 days, will significantly benefit any company involved in the event.
There is great potential in bringing the bio community together – running at the same time as CPhI Worldwide. The launch of bioLIVE will help accelerate the development of the bio supply chain, improve knowledge exchange, and create a more collaborative bio/pharma environment.
Eric Langer, President and Managing Partner, BioPlan Associates
What to expect?
bioLIVE brings excellent science & technology, development and partnering opportunities through cutting edge onsite content and matchmaking.
Exhibit @ bioLIVE:
bioLIVE offers a unique opportunity for any company active in biopharma to put a spotlight on their offering in front of the entire pharma industry.
3000+ executives and senior level attendees responsible for sourcing, procurement, supply chain management, drug development, engineering, research and more from across the biopharma industry.